Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892465055> ?p ?o ?g. }
- W2892465055 endingPage "1157" @default.
- W2892465055 startingPage "1149" @default.
- W2892465055 abstract "Abstract Studies on interventions that can delay or treat frailty in humans are limited. There is evidence of beneficial effects of angiotensin converting enzyme (ACE) inhibitors on aspects related to frailty, such as physical function, even in those without cardiovascular disease. This study aimed to longitudinally investigate the effect of an ACE inhibitor on frailty in aging male and female mice. Frailty was assessed with a clinical frailty index (FI) which quantifies health-related deficits in middle-aged (9–13 months) and older (16–25 months) mice. Chronic treatment with enalapril (30 mg/kg/day in feed) attenuated frailty in middle-aged and older female mice, and older male mice, without a long-term effect on blood pressure. Enalapril treatment resulted in a reduction in the proinflammatory cytokines interleukin (IL)-1α, monocyte chemoattractant protein-1 and macrophage inflammatory protein-1a in older female mice, and an increase in the anti-inflammatory cytokine IL-10 in older male mice compared with control animals. These sex-specific effects on inflammation may contribute to the protective effects of enalapril against frailty. This is the first study to examine the longitudinal effect of an intervention on the FI in mice, and provides preclinical evidence that enalapril may delay the onset of frailty, even when started later in life." @default.
- W2892465055 created "2018-10-05" @default.
- W2892465055 creator A5015232342 @default.
- W2892465055 creator A5044537891 @default.
- W2892465055 creator A5062662633 @default.
- W2892465055 creator A5068641945 @default.
- W2892465055 creator A5069633531 @default.
- W2892465055 date "2018-09-25" @default.
- W2892465055 modified "2023-10-14" @default.
- W2892465055 title "Chronic Treatment With the ACE Inhibitor Enalapril Attenuates the Development of Frailty and Differentially Modifies Pro- and Anti-inflammatory Cytokines in Aging Male and Female C57BL/6 Mice" @default.
- W2892465055 cites W1495554157 @default.
- W2892465055 cites W1526615021 @default.
- W2892465055 cites W1529163119 @default.
- W2892465055 cites W1544712355 @default.
- W2892465055 cites W1586584121 @default.
- W2892465055 cites W1586928599 @default.
- W2892465055 cites W1892870357 @default.
- W2892465055 cites W1964132498 @default.
- W2892465055 cites W1965925676 @default.
- W2892465055 cites W1971214199 @default.
- W2892465055 cites W1982155583 @default.
- W2892465055 cites W1983117789 @default.
- W2892465055 cites W2000642033 @default.
- W2892465055 cites W2008020027 @default.
- W2892465055 cites W2014910485 @default.
- W2892465055 cites W2040542758 @default.
- W2892465055 cites W2055427232 @default.
- W2892465055 cites W2055887038 @default.
- W2892465055 cites W2077136171 @default.
- W2892465055 cites W2077180817 @default.
- W2892465055 cites W2080393351 @default.
- W2892465055 cites W2084583515 @default.
- W2892465055 cites W2086669595 @default.
- W2892465055 cites W2095794384 @default.
- W2892465055 cites W2097173670 @default.
- W2892465055 cites W2102086668 @default.
- W2892465055 cites W2104040341 @default.
- W2892465055 cites W2106108116 @default.
- W2892465055 cites W2108403501 @default.
- W2892465055 cites W2112429003 @default.
- W2892465055 cites W2113870267 @default.
- W2892465055 cites W2117980765 @default.
- W2892465055 cites W2118597903 @default.
- W2892465055 cites W2128275973 @default.
- W2892465055 cites W2129700906 @default.
- W2892465055 cites W2134104241 @default.
- W2892465055 cites W2142137317 @default.
- W2892465055 cites W2143376474 @default.
- W2892465055 cites W2145598786 @default.
- W2892465055 cites W2147945158 @default.
- W2892465055 cites W2148802014 @default.
- W2892465055 cites W2159974907 @default.
- W2892465055 cites W2162490871 @default.
- W2892465055 cites W2162670203 @default.
- W2892465055 cites W2163171037 @default.
- W2892465055 cites W2164490371 @default.
- W2892465055 cites W2168144968 @default.
- W2892465055 cites W2170297033 @default.
- W2892465055 cites W2287109804 @default.
- W2892465055 cites W2396781165 @default.
- W2892465055 cites W2463972536 @default.
- W2892465055 cites W2512384933 @default.
- W2892465055 cites W2518202212 @default.
- W2892465055 cites W2537970767 @default.
- W2892465055 cites W2545605297 @default.
- W2892465055 cites W2564033152 @default.
- W2892465055 cites W2570781645 @default.
- W2892465055 cites W2588345504 @default.
- W2892465055 cites W2591104365 @default.
- W2892465055 cites W2600617028 @default.
- W2892465055 cites W2602303214 @default.
- W2892465055 cites W2612307616 @default.
- W2892465055 cites W2734481251 @default.
- W2892465055 cites W2750535276 @default.
- W2892465055 cites W2767618544 @default.
- W2892465055 cites W2778607002 @default.
- W2892465055 cites W2804083274 @default.
- W2892465055 doi "https://doi.org/10.1093/gerona/gly219" @default.
- W2892465055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6625592" @default.
- W2892465055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30256910" @default.
- W2892465055 hasPublicationYear "2018" @default.
- W2892465055 type Work @default.
- W2892465055 sameAs 2892465055 @default.
- W2892465055 citedByCount "53" @default.
- W2892465055 countsByYear W28924650552018 @default.
- W2892465055 countsByYear W28924650552019 @default.
- W2892465055 countsByYear W28924650552020 @default.
- W2892465055 countsByYear W28924650552021 @default.
- W2892465055 countsByYear W28924650552022 @default.
- W2892465055 countsByYear W28924650552023 @default.
- W2892465055 crossrefType "journal-article" @default.
- W2892465055 hasAuthorship W2892465055A5015232342 @default.
- W2892465055 hasAuthorship W2892465055A5044537891 @default.
- W2892465055 hasAuthorship W2892465055A5062662633 @default.
- W2892465055 hasAuthorship W2892465055A5068641945 @default.
- W2892465055 hasAuthorship W2892465055A5069633531 @default.
- W2892465055 hasBestOaLocation W28924650551 @default.
- W2892465055 hasConcept C11988809 @default.